Bioavailability of a New Oral Suspension of E3810

Update Il y a 5 ans
Reference: EUCTR2016-001896-63

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study was to evaluate the bioavailability of a new rabeprazole formulation, consisting of enteric-coated microgranules, relative to the currently marketed 10-mg tablet formulation.


Inclusion criteria

  • Bioavailability/Bioequivalence

Links